
Punjab Chemicals Q2 FY27: consolidated PAT -27% YoY on margin squeeze, revenue +28%
Punjab Chemicals and Crop Protection's consolidated PAT fell 27.4% YoY to ₹13.46 Cr (₹18.54 Cr a year ago) and 39.0% QoQ (₹22.07 Cr in Q1 FY27), even as consolidated revenue from operations grew 28.0% YoY to ₹326.70 Cr, though it slipped 5.9% QoQ from ₹347.24 Cr. Basic EPS came in at ₹10.98 versus ₹15.12 a year ago and ₹18.00 last quarter. Standalone PAT of ₹13.89 Cr fell a comparatively milder 20.1% YoY, pointing to an added drag from the Belgian subsidiary, SD Agchem (Europe) NV, at the consolidated level. There were no exceptional items in either the current or year-ago quarter, so the decline is entirely on operating performance, not one-offs. The compression sits on the gross-margin line: cost of materials consumed rose to 62.1% of revenue (₹202.75 Cr) from 55.5% a year ago (₹141.57 Cr), outpacing the 28% topline growth and dragging the EBITDA margin (OPM) down to 9.05% from 11.75% in Q1 FY27 and 10.28% a year ago. Finance costs compounded the squeeze, up 50% YoY to ₹5.67 Cr, as the company leaned more on debt: current borrowings jumped to ₹212.79 Cr from ₹104.95 Cr at FY26-end and non-current borrowings to ₹71.75 Cr from ₹37.42 Cr. Net profit margin fell to 4.12% from 7.27% YoY and 6.34% in Q1 FY27. On guidance, management's FY27 target of 15-20% revenue growth (to ₹1,185-1,236 Cr from a ₹1,030 Cr base) remains on track — H1 FY27 consolidated revenue of ₹673.94 Cr is up 17.3% YoY, inside that band. But the EBITDA margin trajectory is moving the wrong way: management had guided a gradual climb to 15% over 2-3 years from a ~12% base, and this quarter printed 9.05%, below even that starting point. We found no analyst consensus for this quarter — Punjab Chemicals carries thin formal coverage with no published revenue/PAT estimates — so the print can't be graded against street numbers, and the company issued no accompanying press release with this filing. Trade receivables more than doubled to ₹453.92 Cr from ₹203.50 Cr at FY26-end, driving H1 operating cash flow to a negative ₹99.40 Cr versus a positive ₹82.96 Cr a year ago and funding the higher borrowings and finance costs above. Separately, the company disclosed a ₹44.96 Cr IGST refund litigation win in August 2026, which is not reflected as income in this quarter's P&L.
Key Highlights
- Consolidated PAT ₹13.46 Cr, down 27.4% YoY (₹18.54 Cr) and 39.0% QoQ (₹22.07 Cr), on revenue of ₹326.70 Cr, up 28.0% YoY but down 5.9% QoQ
- EBITDA margin (OPM) compressed to 9.05% from 10.28% YoY and 11.75% in Q1 FY27; net profit margin fell to 4.12% from 7.27% YoY and 6.34% QoQ
- Cost of materials consumed rose to 62.1% of revenue (₹202.75 Cr) from 55.5% a year ago — the primary margin drag; finance costs up 50% YoY to ₹5.67 Cr
- H1 FY27 consolidated revenue ₹673.94 Cr, +17.3% YoY — inside management's FY27 guidance of 15-20% growth (₹1,185-1,236 Cr full-year target)
- Trade receivables more than doubled to ₹453.92 Cr from ₹203.50 Cr at FY26-end, driving H1 operating cash flow to ₹(99.40) Cr vs +₹82.96 Cr a year ago, funded by borrowings rising to ₹212.79 Cr (current) and ₹71.75 Cr (non-current)
- Won a ₹44.96 Cr IGST refund litigation in August 2026 (per company event records) — not reflected as income in this quarter's P&L
- Consolidated basic EPS ₹10.98 vs ₹15.12 YoY and ₹18.00 QoQ; standalone PAT ₹13.89 Cr fell a milder 20.1% YoY than consolidated
Price Impact
More from PUNJABCHEM